References
- Wickramasinghe SN, Wood WG. Advances in the understanding of the congenital dyserythropoietic anaemias. Br J Haematol. 2005;131:431–446.
- Brittenham GM. Iron-chelating therapy for transfusional iron overload. N Engl J Med. 2011;364:146–156.
- Champagne ET. Low gastric hydrochloric acid secretion and mineral bioavailability. Adv Exp Med Biol. 1989;249:173–184.
- Hutchinson C, Geissler CA, Powell JJ, Bomford A. Proton pump Inhibitor suppress absorption of dietary non-haem iron in hereditary haemochromatosis. Gut. 2007;56:1291–1295.
- Fashner J, Gitu AC. Common gastrointestinal symptoms: irritable bowel syndrome. FP Essent. 2013;413:16–23.
- Taher AT, Porter JB, Viprakasit V, et al. Defining serum ferritin thresholds to predict clinically relevant liver iron concentrations for guiding deferasirox therapy when MRI is unavailable in patients with non-transfusion-dependent thalassaemia. Br J Haematol. 2015;168:284–290.
- Heimpel H, Schwarz K, Ebnother M, et al. Congenital dyserythropoietic anemia type I (CDA I): molecular genetics, clinical appearance, and prognosis based on long term observation. Blood. 2006;107:334–401.
- Miret S, Simpson RJ, McKie AT. Physiology and molecular biology of Dietary iron absorption. Annu Rev Nutr. 2003;23:283–301.
- Skikne BS, Lynch SR, Cook JD. Role of gastric acid in food iron absorption. Gastroenterology. 1981;81:1068–1071.
- Eghbali A, Taherahmadi H, Shahbazi M, Bagheri B, Ebrahimi L. Association between serum ferritin level, cardiac and hepatic T2-star MRI in patients with major β-thalassemia. Iran J Ped Hematol Oncol. 2014:417–421.
- Rivella S. The role of ineffective erythropoiesis in non-transfusion dependent thalassemia. Blood Rev. 2012;26:S12–S15.
- Pippard MJ, Callender ST, Warner GT, Weatherall DJ. Iron absorption and loading in beta-thalassaemia intermedia. Lancet. 1979;2:819–821.
- Koop H, Bachem MG. Serum iron, ferritin, and vitamin B12 during prolonged omeprazole therapy. J Clin Gastroenterol. 1992;14:288–292.
- Tempel M, Chawla A, Messina C, Celiker MY. Effects of omeprazole on Iron absorption: preliminary study. Turk J Haematol. 2013;30:307–310.
- Ajmera AV, Shastri GS, Gajera MJ, Judge TA. Suboptimal response to ferrous sulfate in iron-deficient patients taking omeprazole. Am J Ther. 2012;19:185–189.
- Sharma VR, Brannon MA, Carloss EA. Effect of omeprazole on oral iron in patients with iron deficiency anemia. South Med J. 2004;97:887–889.